“…Expression vectors for Y14, TNFR, NF-kB/p65, p50, p100, c-Rel, RIP1, TRADD, TRAF2/5, TAK1, NEMO, IKKa/b, IL-6 promoter-luciferase (pIL-6-LUC), and NF-kB-luciferase (NF-kB-LUC) were kindly provided by J. Inoue (Tokyo University, Tokyo, Japan), T. Kobayashi (Keio University, Tokyo, Japan), T. Fujita (Kyoto University, Kyoto, Japan), S. Akira (Osaka University), and H. Sakurai (Toyama University, Toyama, Japan) (22)(23)(24)(25). Expression vectors for Y14 were described previously (20,21). Anti-Y14, anti-MAGOH, anti-NF-kB/p65, anti-IkBa, anti-STAT3, anti-p300, anti-TRADD, and anti-Myc Abs were obtained from Santa Cruz Biotechnology (Santa Cruz, CA); anti-FLAG, anti-HA Abs were from Sigma-Aldrich (St. Louis, MO); anti-acetyl-NF-kB/p65 (Lys310), anti-pIkBa (Ser 32/36 ), and anti-pSTAT3 (Tyr 705 ) Abs were from Cell Signaling Technology (Beverly, MA); anti-RIP1 and anti-pSTAT3 (Ser 727 ) Abs were from GE Healthcare Life Sciences (Tokyo, Japan); anti-TRAF2 Ab was from AnaSpec (Fremont, CA); and anti-actin Ab was from Millipore (Billerica, MA).…”